SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001255627-20-000002
Filing Date
2020-09-10
Accepted
2020-09-10 17:35:49
Documents
1
Period of Report
2020-09-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3761
  Complete submission text file 0001255627-20-000002.txt   5439
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 15 TROTTERS LANE MONROE CT 06468
Business Address
SCHREIBER DAVID (Reporting) CIK: 0001255627 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34810 | Film No.: 201169397